Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
abbvie
4
×
astrazeneca
4
×
biotech
boston blog main
boulder/denver blog main
boulder/denver top stories
cancer
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
4
×
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
boston top stories
cancer immunotherapy
clinical trials
deals
eli lilly
fda
pfizer
alzheimer's disease
biogen
bristol-myers squibb
What
bio
roundup
drug
acquisitions
ceo
daniel
gilead
o’day
sciences
week
alzheimer’s
announced
annual
approved
assessed
attention
biggest
biotech
build
buy
collabs
communities
companies
company’s
conference
covid
deal
debut
digital
disease
dyne’s
epidemic
esmo
europe
fatty
fda
frenzied
germany
gilead’s
growing
Language
unset
Current search:
astrazeneca
×
abbvie
×
startups
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
5 years ago
Bio Roundup: NASH News, Merck Strikes, Digital Tokens & More
@xconomy.com
5 years ago
Bio Roundup: Alzheimer’s Puzzle, ESMO Assessed, Drug Prices & More